Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page or its documentation rather than substantive changes to the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.5.4 has been added and the previous revision v3.5.3 has been removed, indicating an update to the documented revision history.SummaryDifference0.0%

- Check47 days agoChange DetectedThe study record shows updated metadata: the sponsor/links section and “last update” timing reflect a more recent posting (2026-04-24 and 2026-04-10/2026-04). Some study location entries have also changed by removing added ZIP+4 details, while the core study description and clinical components remain the same.SummaryDifference0.5%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision: v3.4.3 was added to the documentation and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.